Literature DB >> 28587553

Guidelines of the Brazilian Association of Studies on Alcohol and Other Drugs (ABEAD) for diagnosis and treatment of psychiatric comorbidity with alcohol and other substance and dependence.

Marcos Zaleski1,2, Ronaldo Ramos Laranjeira3, Ana Cecília Petta Roselli Marques3, Lílian Ratto4, Marcos Romano3, Hamer Nastasy Palhares Alves3, Márcia Britto de Macedo Soares5, Valter Abelardino6, Félix Kessler7, Sílvia Brasiliano8, Sérgio Nicastri9, Patrícia Brunferntrinker Hochgraf8, Analice de Paula Gigliotti10,11, Tadeu Lemos1,2.   

Abstract

In recent years, several studies have been focused on the comorbidity of psychiatric disorders with alcohol and other substance dependence. In this context, the Brazilian Association of Studies on Alcohol and Other Drugs initiated a project to establish Brazilian Guidelines. The aim of this study was to review diagnostic and therapeutic criteria for the most prevalent psychiatric comorbidities. Randomized clinical trials, epidemiological studies, animal testing and other forms of research are reviewed herein. The main psychiatric comorbidities are investigated and data published in the literature are reviewed, based on guidelines adopted by other countries. Epidemiological aspects, diagnostic criteria, integrated treatment and the organization of specialized service, as well as details regarding psychotherapy and pharmacological treatment are discussed. The guidelines of the Brazilian Association of Studies on Alcohol and Other Drugs reinforce the importance of adequate diagnosis and treatment regarding alcoholic and drug dependent patients suffering of comorbid psychiatric disorders.

Entities:  

Keywords:  Substance-related disorders; combined modality therapy; comorbidity; diagnosis; practice guidelines

Mesh:

Year:  2017        PMID: 28587553     DOI: 10.1080/09540261.2017.1285552

Source DB:  PubMed          Journal:  Int Rev Psychiatry        ISSN: 0954-0261


  1 in total

Review 1.  Concurrent Disorder Management Guidelines. Systematic Review.

Authors:  Syune Hakobyan; Sara Vazirian; Stephen Lee-Cheong; Michael Krausz; William G Honer; Christian G Schutz
Journal:  J Clin Med       Date:  2020-07-28       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.